TCG Crossover Management’s Entera Bio ENTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$35.7M Buy
+12,254,901
New +$32.7M 1.01% 27

Other funds holding ENTX

TCG Crossover Management's ENTX Position: Q3 2026 in Review

TCG Crossover Management opened a new position in Entera Bio (ENTX) in Q3 2026: 12,254,901 shares worth $35.7M. The stake represents 1.01% of the portfolio and ranks #27 among its holdings.

45 funds tracked by Wall St. Rank hold ENTX as of Q3 2026.

  • TCG Crossover Management held 12,254,901 shares of Entera Bio worth $35.7M as of Q3 2026.
  • Entera Bio was a new TCG Crossover Management position in Q3 2026.
  • Entera Bio made up 1.01% of TCG Crossover Management's portfolio in Q3 2026, its #27 holding.
  • 45 funds tracked by Wall St. Rank held Entera Bio as of Q3 2026.

Based on TCG Crossover Management's 13F filing for Q3 2026, filed 16 Nov 2026.